Technical Description
The present invention relates to the development of ferulic acid-based compounds having significant inhibition of dual cholinesterase and antioxidant activity for the treatment of Alzheimer disease.
Problems Addressed
- Limitations of Existing Treatments
- Lack of Multifunctional Therapeutics
- Oxidative Stress
- Poor Cholinergic Inhibition Specificity
- No Disease Progression Prevention
- Inadequate BBB Permeability
Tech Features
- Novel Multifunctional Compound
- Dual Cholinesterases Inhibition
- Antioxidant Activity
- Targeted Drug Delivery
- Exhibits Metal Chelation
- High Drug Yield
- Enhanced BBB Permeability
- Low IC50 Value
- Prevents Alzheimer Disease Progression
- Oxidative Stress Reduction
Target Audience
- Healthcare & Medical Sector
- Medical Laboratories
- Diagnostic Industry
- Research & Development
Tech ID: P27-1255 TRL 4 Patent Status: Granted Available For Exclusive and Non-exclusive License
